Invasive versus noninvasive management of older patients with non-ST elevation ACS: A retrospective analysis
Preprint
- 19 April 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose: The aim of this study was to evaluate the efficacy of invasive versus noninvasive management in patients aged 80 years or older with non-ST-elevation acute coronary syndrome (NSTEACS). Methods: All 220 included patients were at least 80 years old at the time of diagnosis. We compared the prognoses of patients in the invasive group and the noninvasive group. The primary endpoint was all-causemortality, and the secondary endpoint was the occurrence of events, including readmission or visit to a chest pain center due to a myocardial ischemic event, heart failure or major bleeding. Results: The median age was 84 years (IQR 83-87), and older patients were more likely to receive noninvasiveinterventions (OR 0.82, 95% CI 0.74-0.92). The mortality HR when comparing noninvasive management with invasive management was 5.52 (95% CI1.80-16.92). When adjusted for diagnosis (UA or NSTEMI), the mortality HR increased to 6.17 (95% CI 2.04-18.64). Noninvasive management was associated with a higher incidence of events (HR 2.96, 95% CI1.51-5.82). However, no significant differences were observed in mortality or event HR when comparing complete revascularization with culprit-only percutaneous coronary intervention (PCI). Conclusions: For patients aged 80 years or older with NSTEACS, invasive management might be a better choice than noninvasive management. In terms of PCI strategy, culprit-only PCI could be considered.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical dataThe Lancet, 2020
- Complete Revascularization in Patients With STEMI and Multi-Vessel Disease: A Meta-Analysis of Randomized Controlled TrialsCardiovascular Revascularization Medicine, 2020
- Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S.Scientific Reports, 2019
- One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 studyInternational Journal of Cardiology, 2019
- Routine Invasive Versus Selective Invasive Strategy in Elderly Patients Older Than 75 Years With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Meta-AnalysisMayo Clinic Proceedings, 2018
- Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trialThe Lancet, 2016
- Coronary revascularisation in older patients with non-ST elevation acute coronary syndromesHeart, 2016
- Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trialThe Lancet, 2015
- Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)American Heart Journal, 2005
- Predictors of Hospital Mortality in the Global Registry of Acute Coronary EventsArchives of internal medicine (1960), 2003